{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T18:19:13Z","timestamp":1776449953745,"version":"3.51.2"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"5-6","license":[{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Wien Klin Wochenschr"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1007\/s00508-011-1532-4","type":"journal-article","created":{"date-parts":[[2011,2,25]],"date-time":"2011-02-25T06:31:36Z","timestamp":1298615496000},"page":"145-155","source":"Crossref","is-referenced-by-count":11,"title":["Are renal adverse effects of hydroxyethyl starches merely a consequence of their incorrect use?","Renale Nebenwirkungen von Hydroxy\u00e4thylst\u00e4rke \u2013 lediglich Folge des \"unsachgem\u00e4\u00dfen\" Gebrauchs?"],"prefix":"10.1007","volume":"123","author":[{"given":"Christiane S.","family":"Hartog","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank M.","family":"Brunkhorst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Engel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Meier-Hellmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maximilian","family":"Ragaller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tobias","family":"Welte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evelyn","family":"Kuhnt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konrad","family":"Reinhart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,3,1]]},"reference":[{"issue":"2","key":"1532_CR1","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1056\/NEJMoa070716","volume":"358","author":"FM Brunkhorst","year":"2008","unstructured":"Brunkhorst FM, Engel C, Bloos F, et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 2008;358(2):125\u201339","journal-title":"N Engl J Med"},{"key":"1532_CR2","unstructured":"Finfer S, McEvoy S, Bellomo R, et al. Impact of albumin compared to saline on organ function and mortality of patients with severe sepsis. Intensive Care Med 2011; in press"},{"issue":"3","key":"1532_CR3","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/s15010-008-8203-z","volume":"37","author":"R Beale","year":"2009","unstructured":"Beale R, Reinhart K, Brunkhorst FM, et al. Promoting Global Research Excellence in Severe Sepsis (PROGRESS): lessons from an international sepsis registry. Infection 2009;37(3):222\u201332","journal-title":"Infection"},{"key":"1532_CR4","first-page":"309","volume":"47","author":"J Boldt","year":"2006","unstructured":"Boldt J, Schollhorn T, Dieterich HJ. Fluid therapy in Germany \u2013 results of a postal survey. Anasthesiologie & Intensivmedizin 2006;47:309\u201314","journal-title":"Anasthesiologie & Intensivmedizin"},{"issue":"6","key":"1532_CR5","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1055\/s-2007-995067","volume":"32","author":"MG Dehne","year":"1997","unstructured":"Dehne MG, Muhling J, Sablotzki A, et al. Effect of hydroxyethyl starch solution on kidney function in surgical intensive care patients. Anasthesiol Intensivmed Notfallmed Schmerzther 1997;32(6):348\u201354","journal-title":"Anasthesiol Intensivmed Notfallmed Schmerzther"},{"issue":"9260","key":"1532_CR6","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/S0140-6736(00)04211-2","volume":"357","author":"F Schortgen","year":"2001","unstructured":"Schortgen F, Lacherade JC, Bruneel F, et al. Effects of hydroxyethylstarch and gelatin on renal function in severe sepsis: a multicentre randomised study. Lancet 2001;357(9260):911\u20136","journal-title":"Lancet"},{"issue":"4","key":"1532_CR7","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1097\/CCM.0b013e31819cc1a0","volume":"37","author":"JP Rioux","year":"2009","unstructured":"Rioux JP, Lessard M, De Bortoli B, et al. Pentastarch 10% (250 kDa\/0.45) is an independent risk factor of acute kidney injury following cardiac surgery. Crit Care Med 2009;37(4):1293\u20138","journal-title":"Crit Care Med"},{"issue":"9","key":"1532_CR8","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1007\/s00134-009-1509-1","volume":"35","author":"F Schabinski","year":"2009","unstructured":"Schabinski F, Oishi J, Tuche F, et al. Effects of a predominantly hydroxyethyl starch (HES)-based and a predominantly non HES-based fluid therapy on renal function in surgical ICU patients. Intensive Care Med 2009;35(9):1539\u201347","journal-title":"Intensive Care Med"},{"issue":"4","key":"1532_CR9","first-page":"E196","volume":"3","author":"R Zarychanski","year":"2009","unstructured":"Zarychanski R, Turgeon AF, Fergusson DA, et al. Renal outcomes and mortality following hydroxyethyl starch resuscitation of critically ill patients: systematic review and meta-analysis of randomized trials. Open Med 2009;3(4):E196\u2013209","journal-title":"Open Med"},{"issue":"7\u20138","key":"1532_CR10","first-page":"441","volume":"73","author":"CJ Wiedermann","year":"2007","unstructured":"Wiedermann CJ. Renal failure in septic patients receiving hydroxyethyl starch. Minerva Anestesiol 2007;73(7\u20138):441","journal-title":"Minerva Anestesiol"},{"key":"1532_CR11","doi-asserted-by":"crossref","unstructured":"Dart AB, Mutter TC, Ruth CA, et al. Hydroxyethyl starch (HES) versus other fluid therapies: effects on kidney function. Cochrane Database Syst Rev 2010;1:CD007594","DOI":"10.1002\/14651858.CD007594.pub2"},{"issue":"9","key":"1532_CR12","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1007\/s001010050625","volume":"47","author":"J Boldt","year":"1998","unstructured":"Boldt J. [Volume replacement in critically ill intensive-care patients. No classic review]. Anaesthesist 1998;47(9):778\u201385","journal-title":"Anaesthesist"},{"key":"1532_CR13","doi-asserted-by":"crossref","unstructured":"Gosling P, Rittoo D, Manji M, et al. Hydroxyethylstarch as a risk factor for acute renal failure in severe sepsis. Lancet. 2001;358(9281):(581; author reply 582)","DOI":"10.1016\/S0140-6736(01)05718-X"},{"issue":"9281","key":"1532_CR14","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0140-6736(01)05720-8","volume":"358","author":"J Boldt","year":"2001","unstructured":"Boldt J. Hydroxyethylstarch as a risk factor for acute renal failure in severe sepsis. Lancet 2001;358(9281):581\u20133","journal-title":"Lancet"},{"issue":"2","key":"1532_CR15","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1055\/s-2004-817674","volume":"39","author":"S Suttner","year":"2004","unstructured":"Suttner S, Boldt J. [Volume replacement with hydroxyethyl starch: is there an influence on kidney function?]. Anasthesiol Intensivmed Notfallmed Schmerzther 2004;39(2):71\u20137","journal-title":"Anasthesiol Intensivmed Notfallmed Schmerzther"},{"key":"1532_CR16","doi-asserted-by":"crossref","unstructured":"Bracco D, Schricker T, Carvalho G. Insulin and pentastarch for severe sepsis. N Engl J Med 2008;358(19):(2072; author reply 2074\u20135)","DOI":"10.1056\/NEJMc080223"},{"issue":"1","key":"1532_CR17","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s00101-006-1122-4","volume":"56","author":"R Zander","year":"2007","unstructured":"Zander R, Boldt J, Engelmann L, et al. The design of the VISEP trial. Critical appraisal. Anaesthesist 2007;56(1):71\u20137","journal-title":"Anaesthesist"},{"key":"1532_CR18","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s00390-008-0887-x","volume":"45","author":"L Engelmann","year":"2008","unstructured":"Engelmann L. Die VISEP-Studie: ein Schritt vorw\u00e4rts, zwei Schritte zur\u00fcck. Intensivmed 2008;45:255\u201362","journal-title":"Intensivmed"},{"key":"1532_CR19","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/ALN.0b013e3181a7ec82","volume":"111","author":"M Westphal","year":"2009","unstructured":"Westphal M, James MF, Kozek-Langenecker S, et al. Hydroxyethyl starches: different products \u2013 different effects. Anesthesiology 2009;111:187\u2013202","journal-title":"Anesthesiology"},{"key":"1532_CR20","first-page":"338","volume":"50","author":"H Van Aken","year":"2009","unstructured":"Van Aken H, Jacob M, Westphal M, et al. Infusion therapy in anaesthesiology and intensive care medicine: yesterday, today and tomorrow. [Infusionstherapie in der Anaesthesiologie und Intensivmedizin: Gestern, heute und morgen]. Anaesth Intensivmed 2009;50:338\u201345","journal-title":"Anaesth Intensivmed"},{"issue":"4","key":"1532_CR21","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1007\/s00134-006-0517-7","volume":"33","author":"C Engel","year":"2007","unstructured":"Engel C, Brunkhorst FM, Bone HG, et al. Epidemiology of sepsis in Germany: results from a national prospective multicenter study. Intensive Care Med 2007;33(4):606\u201318","journal-title":"Intensive Care Med"},{"issue":"3","key":"1532_CR22","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s00134-009-1736-5","volume":"36","author":"CS Hartog","year":"2010","unstructured":"Hartog CS, Brunkhorst FM, Bloos F, et al. Practice of volume therapy in patients with severe sepsis: results from a nationwide sepsis prevalence study. Intensive Care Med 2010;36(3):553\u20134","journal-title":"Intensive Care Med"},{"key":"1532_CR23","unstructured":"Ehrly AM, H\u00f6rl WH, Schmitz JE, et al. Stellungnahme zu der Bekanntgabe der Arzneimittelkommission der Deutschen \u00c4rzteschaft: Nochmals: \"Vorsicht bei H\u00e4modilutionstherapie mit Hydroxy\u00e4thylst\u00e4rke (HES)\". Dtsch \u00c4rztebl 1993;90(B2454)"},{"key":"1532_CR24","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1055\/s-2008-1027938","volume":"16","author":"S Rehberg","year":"2008","unstructured":"Rehberg S, Ertmer C, Ellger B, et al. Perioperative Fl\u00fcssigkeitstherapie. Intensivmed 2008;16:288\u201394","journal-title":"Intensivmed"},{"key":"1532_CR25","doi-asserted-by":"crossref","unstructured":"Schortgen F, Brochard L. Hydroxyethylstarch as a risk factor for acute renal failure in severe sepsis. Lancet 2001;358(9281):(582\u2013583, author reply)","DOI":"10.1016\/S0140-6736(01)05721-X"},{"key":"1532_CR26","doi-asserted-by":"crossref","unstructured":"Brunkhorst FM, Reinhart K, Engel C. Insulin and Pentastarch for Severe Sepsis. N Engl J Med 2008;358(19):(2074, author reply)","DOI":"10.1056\/NEJMc080223"},{"issue":"7","key":"1532_CR27","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s00101-008-1391-1","volume":"57","author":"K Reinhart","year":"2008","unstructured":"Reinhart K, Brunkhorst FM, Engel C. et al. Study protocol of the VISEP study. Response of the SepNet study group. Anaesthesist 2008;57(7):723\u20138","journal-title":"Anaesthesist"},{"key":"1532_CR28","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00390-008-0927-6","volume":"45","author":"FM Brunkhorst","year":"2008","unstructured":"Brunkhorst FM, K. R. Die VISEP-Studie richtig gelesen \u2013 zwei Schritte vorw\u00e4rts und kein Schritt zur\u00fcck [The VISEP study \u2013 two steps forward and no step backwards]. Intensivmed 2008;45:427\u201339","journal-title":"Intensivmed"},{"issue":"2","key":"1532_CR29","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s001340050536","volume":"24","author":"J Boldt","year":"1998","unstructured":"Boldt J, Lenz M, Kumle B, et al. Volume replacement strategies on intensive care units: results from a postal survey. Intensive Care Med 1998;24(2):147\u201351","journal-title":"Intensive Care Med"},{"issue":"7","key":"1532_CR30","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1007\/s00134-002-1337-z","volume":"28","author":"MS Miletin","year":"2002","unstructured":"Miletin MS, Stewart TE, Norton PG. Influences on physicians' choices of intravenous colloids. Intensive Care Med 2002;28(7):917\u201324","journal-title":"Intensive Care Med"},{"issue":"12","key":"1532_CR31","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1007\/s00134-004-2415-1","volume":"30","author":"F Schortgen","year":"2004","unstructured":"Schortgen F, Deye N, Brochard L. Preferred plasma volume expanders for critically ill patients: results of an international survey. Intensive Care Med 2004;30(12):2222\u20139","journal-title":"Intensive Care Med"},{"key":"1532_CR32","unstructured":"Haljamae H. Swedish practice routines for fluid therapy are considerably changing. Lakartidningen 2005;102(38):(2659\u20132662, 2664\u20132655)"},{"issue":"3","key":"1532_CR33","first-page":"162","volume":"54","author":"M Basora","year":"2007","unstructured":"Basora M, Moral V, Llau JV, et al. Perioperative colloid administration: a survey of Spanish anesthesiologists' attitudes. Rev Esp Anestesiol Reanim 2007;54(3):162\u20138","journal-title":"Rev Esp Anestesiol Reanim"},{"issue":"3","key":"1532_CR34","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/j.1399-6576.2006.01190.x","volume":"51","author":"M Kastrup","year":"2007","unstructured":"Kastrup M, Markewitz A, Spies C, et al. Current practice of hemodynamic monitoring and vasopressor and inotropic therapy in post-operative cardiac surgery patients in Germany: results from a postal survey. Acta Anaesthesiol Scand 2007;51(3):347\u201358","journal-title":"Acta Anaesthesiol Scand"},{"issue":"4","key":"1532_CR35","doi-asserted-by":"crossref","first-page":"R74","DOI":"10.1186\/cc5962","volume":"11","author":"LA McIntyre","year":"2007","unstructured":"McIntyre LA, Hebert PC, Fergusson D, et al. A survey of Canadian intensivists' resuscitation practices in early septic shock. Crit Care 2007;11(4):R74","journal-title":"Crit Care"},{"key":"1532_CR36","doi-asserted-by":"crossref","unstructured":"Anonymous. Preferences for colloid use in Scandinavian intensive care units. Acta Anaesthesiol Scand 2008;52(6):750\u20138","DOI":"10.1111\/j.1399-6576.2008.01690.x"},{"issue":"15\u201316","key":"1532_CR37","first-page":"304","volume":"9","author":"C Hagne","year":"2009","unstructured":"Hagne C, Schwarz A, Gaspert A, et al. HAES in septic shock \u2013 sword of Damocles? Schweiz Med Forum 2009;9(15\u201316):304\u20136","journal-title":"Schweiz Med Forum"},{"key":"1532_CR38","doi-asserted-by":"crossref","unstructured":"Boldt J. Limited Dosage for HES? Anasthesiol Intensivmed Notfallmed Schmerzther. 2001;36 Suppl 2:S102\u20133","DOI":"10.1055\/s-2001-18182"},{"issue":"8","key":"1532_CR39","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/S0750-7658(02)00695-0","volume":"21","author":"Y Blanloeil","year":"2002","unstructured":"Blanloeil Y, Trossaert M, Rigal JC, et al. Effects of plasma substitutes on hemostasis. Ann Fr Anesth Reanim. 2002;21(8):648\u201367","journal-title":"Ann Fr Anesth Reanim"},{"issue":"2","key":"1532_CR40","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1213\/00000539-200302000-00014","volume":"96","author":"J Boldt","year":"2003","unstructured":"Boldt J, Priebe HJ. Intravascular volume replacement therapy with synthetic colloids: is there an influence on renal function? Anesth Analg 2003;96(2):376\u201382","journal-title":"Anesth Analg"},{"issue":"2","key":"1532_CR41","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/cc7745","volume":"13","author":"F Schortgen","year":"2009","unstructured":"Schortgen F, Brochard L. Colloid-induced kidney injury: experimental evidence may help to understand mechanisms. Crit Care 2009;13(2):130","journal-title":"Crit Care"},{"key":"1532_CR42","first-page":"283","volume":"19","author":"WL Thompson Jr","year":"1978","unstructured":"Thompson WL, Jr. Hydroxyethyl starch. Prog Clin Biol Res 1978;19:283\u201392","journal-title":"Prog Clin Biol Res"},{"issue":"3","key":"1532_CR43","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1056\/NEJM198707163170306","volume":"317","author":"M Moran","year":"1987","unstructured":"Moran M, Kapsner C. Acute renal failure associated with elevated plasma oncotic pressure. N Engl J Med 1987;317(3):150\u20133","journal-title":"N Engl J Med"},{"issue":"3","key":"1532_CR44","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1053\/j.ajkd.2007.10.044","volume":"51","author":"M Dickenmann","year":"2008","unstructured":"Dickenmann M, Oettl T, Mihatsch MJ. Osmotic nephrosis: acute kidney injury with accumulation of proximal tubular lysosomes due to administration of exogenous solutes. Am J Kidney Dis 2008;51(3):491\u2013503","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"1532_CR45","doi-asserted-by":"crossref","first-page":"R23","DOI":"10.1186\/cc7726","volume":"13","author":"L Huter","year":"2009","unstructured":"Huter L, Simon TP, Weinmann L, et al. Hydroxyethylstarch impairs renal function and induces interstitial proliferation, macrophage infiltration and tubular damage in an isolated renal perfusion model. Crit Care 2009;13(1):R23","journal-title":"Crit Care"},{"issue":"48","key":"1532_CR46","first-page":"882","volume":"9","author":"A Schwarz","year":"2009","unstructured":"Schwarz A, Keusch G. Replik. Schweiz Med Forum 2009;9(48):882\u20133","journal-title":"Schweiz Med Forum"},{"issue":"5\u20136","key":"1532_CR47","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/BF03040482","volume":"116","author":"J Boldt","year":"2004","unstructured":"Boldt J. Hydroxyethylstarch (HES). Wien Klin Wochenschr 2004;116(5\u20136):159\u201369","journal-title":"Wien Klin Wochenschr"},{"issue":"1","key":"1532_CR48","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s001340050511","volume":"24","author":"J Boldt","year":"1998","unstructured":"Boldt J, Muller M, Mentges D, et al. Volume therapy in the critically ill: is there a difference? Intensive Care Med 1998;24(1):28\u201336","journal-title":"Intensive Care Med"},{"issue":"12","key":"1532_CR49","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1007\/s00134-008-1225-2","volume":"34","author":"F Schortgen","year":"2008","unstructured":"Schortgen F, Girou E, Deye N, et al. The risk associated with hyperoncotic colloids in patients with shock. Intensive Care Med 2008;34(12):2157\u201368","journal-title":"Intensive Care Med"},{"issue":"2","key":"1532_CR50","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1093\/bja\/ael333","volume":"98","author":"Y Sakr","year":"2007","unstructured":"Sakr Y, Payen D, Reinhart K, et al. Effects of hydroxyethyl starch administration on renal function in critically ill patients. Br J Anaesth 2007;98(2):216\u201324","journal-title":"Br J Anaesth"},{"issue":"3","key":"1532_CR51","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1213\/00000539-200209000-00007","volume":"95","author":"C Jungheinrich","year":"2002","unstructured":"Jungheinrich C, Scharpf R, Wargenau M, et al. The pharmacokinetics and tolerability of an intravenous infusion of the new hydroxyethyl starch 130\/0.4 (6%, 500 mL) in mild-to-severe renal impairment. Anesth Analg 2002;95(3):544\u201351","journal-title":"Anesth Analg"},{"issue":"5","key":"1532_CR52","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1213\/01.ANE.0000061582.09963.FD","volume":"96","author":"TA Neff","year":"2003","unstructured":"Neff TA, Doelberg M, Jungheinrich C, et al. Repetitive large-dose infusion of the novel hydroxyethyl starch 130\/0.4 in patients with severe head injury. Anesth Analg 2003;96(5):1453\u20139","journal-title":"Anesth Analg"},{"issue":"3","key":"1532_CR53","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1007\/s00134-008-1287-1","volume":"35","author":"J Boldt","year":"2009","unstructured":"Boldt J, Suttner S, Brosch C, et al. The influence of a balanced volume replacement concept on inflammation, endothelial activation, and kidney integrity in elderly cardiac surgery patients. Intensive Care Med 2009;35(3):462\u201370","journal-title":"Intensive Care Med"},{"issue":"4","key":"1532_CR54","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1093\/bja\/aen016","volume":"100","author":"J Boldt","year":"2008","unstructured":"Boldt J, Brosch C, Rohm K, et al. Comparison of the effects of gelatin and a modern hydroxyethyl starch solution on renal function and inflammatory response in elderly cardiac surgery patients. Br J Anaesth 2008;100(4):457\u201364","journal-title":"Br J Anaesth"},{"key":"1532_CR55","doi-asserted-by":"crossref","unstructured":"Godet G, Lehot JJ, Janvier G, Steib A, De Castro V, Coriat P. Safety of HES 130\/0.4 (Voluven(R)) in patients with preoperative renal dysfunction undergoing abdominal aortic surgery: a prospective, randomized, controlled, parallel-group multicentre trial. [erratum appears in Eur J Anaesthesiol 2008 Dec;25(12):1042] Eur J Anaesthesiol 2008;25:986\u201394","DOI":"10.1017\/S026502150800447X"},{"issue":"5","key":"1532_CR56","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1001\/archsurg.139.5.552","volume":"139","author":"ME Barron","year":"2004","unstructured":"Barron ME, Wilkes MM, Navickis RJ. A systematic review of the comparative safety of colloids. Arch Surg 2004;139(5):552\u201363","journal-title":"Arch Surg"},{"issue":"3","key":"1532_CR57","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s00134-009-1704-0","volume":"36","author":"MA Schick","year":"2010","unstructured":"Schick MA, Isbary TJ, Schlegel N, et al. The impact of crystalloid and colloid infusion on the kidney in rodent sepsis. Intensive Care Med 2010;36(3):541\u20138","journal-title":"Intensive Care Med"},{"issue":"5","key":"1532_CR58","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1213\/ane.0b013e31818370b2","volume":"107","author":"J Boldt","year":"2008","unstructured":"Boldt J, Brosch C, Rohm K, et al. Is albumin administration in hypoalbuminemic elderly cardiac surgery patients of benefit with regard to inflammation, endothelial activation, and long-term kidney function? Anesth Analg 2008;107(5):1496\u2013503","journal-title":"Anesth Analg"},{"issue":"7","key":"1532_CR59","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1111\/j.1399-6576.2005.00714.x","volume":"49","author":"C Fenger-Eriksen","year":"2005","unstructured":"Fenger-Eriksen C, Hartig Rasmussen C, Kappel Jensen T, et al. Renal effects of hypotensive anaesthesia in combination with acute normovolaemic haemodilution with hydroxyethyl starch 130\/0.4 or isotonic saline. Acta Anaesthesiol Scand 2005;49(7):969\u201374","journal-title":"Acta Anaesthesiol Scand"},{"issue":"12","key":"1532_CR60","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1097\/01.CCM.0000288101.02556.DE","volume":"35","author":"J Boldt","year":"2007","unstructured":"Boldt J, Brosch C, Ducke M, et al. Influence of volume therapy with a modern hydroxyethylstarch preparation on kidney function in cardiac surgery patients with compromised renal function: a comparison with human albumin. Crit Care Med 2007;35(12):2740\u20136","journal-title":"Crit Care Med"},{"key":"1532_CR61","unstructured":"FDA NDA REVIEW MEMO (MID-CYCLE). US Department of Health and Human Services, Public health service, Food and Drug Administration. 2007 [assessed on 13th November 2009]. Available from: http:\/\/www.fda.gov\/downloads\/BiologicsBloodVaccines\/BloodBloodProducts\/ApprovedProducts\/NewDrugApplicationsNDAs\/UCM083393.pdf ."},{"issue":"3","key":"1532_CR62","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1213\/ANE.0b013e31820ad607","volume":"112","author":"CS Hartog","year":"2011","unstructured":"Hartog CS, Kohl M, Reinhart K. A systematic review of 3rd generation hydroxyethyl starch (HES 130\/0.4) in resuscitation: safety not adequately addressed. Anesth Analg 2011;112(3):635\u201345","journal-title":"Anesth Analg"},{"issue":"12","key":"1532_CR63","first-page":"741","volume":"71","author":"J Boldt","year":"2005","unstructured":"Boldt J, Suttner S. Plasma substitutes. Minerva Anestesiol 2005;71(12):741\u201358","journal-title":"Minerva Anestesiol"},{"issue":"2","key":"1532_CR64","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1093\/bja\/aep194","volume":"103","author":"J Boldt","year":"2009","unstructured":"Boldt J. Seven misconceptions regarding volume therapy strategies \u2013 and their correction. Br J Anaesth 2009;103(2):147\u201351","journal-title":"Br J Anaesth"},{"issue":"8","key":"1532_CR65","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1007\/s00134-009-1520-6","volume":"35","author":"J Boldt","year":"2009","unstructured":"Boldt J. PRO: hydroxyethylstarch can be safely used in the intensive care patient \u2013 the renal debate. Intensive Care Med 2009;35(8):1331\u20136","journal-title":"Intensive Care Med"}],"container-title":["Wiener klinische Wochenschrift"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00508-011-1532-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00508-011-1532-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00508-011-1532-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,19]],"date-time":"2021-11-19T13:56:18Z","timestamp":1637330178000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00508-011-1532-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3]]},"references-count":65,"journal-issue":{"issue":"5-6","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["1532"],"URL":"https:\/\/doi.org\/10.1007\/s00508-011-1532-4","relation":{},"ISSN":["0043-5325","1613-7671"],"issn-type":[{"value":"0043-5325","type":"print"},{"value":"1613-7671","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,3]]}}}